Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

RTP to accelerate development of insoluble drug delivery technology

Dec. 5, 1996

Incyte and Abbott expand genomic database agreement

Dec. 5, 1996

Patent issued for Vical's core technology

Dec. 5, 1996

Neurochem/Parke-Davis collaboration on antiamyloid compounds

Dec. 4, 1996

Forbes Medi-Tech awarded research grant

Dec. 4, 1996

BMS-Aurora research agreement on screening technology

Dec. 4, 1996

Zeneca and Rutgers collaborate on apoptosis research

Dec. 4, 1996

Incyte-Affymetrix to develop and commercialize new chip-based genomic databases

Dec. 2, 1996

Expanded patent portfolio for Dyax technology

Dec. 2, 1996

Methods for screening for neurotoxicity offered for licensing

Dec. 2, 1996

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...